Evidence map›Paper›PMID 42231910›Full record

ArticleCurrent developments in nutrition2026

A Diverse Fiber Mixture, Reflective of a Nutritionally Balanced Diet, Is Well Tolerated by Healthy Adults.

Lotte Dopheide, Marta Kozior, Amra Buco, Jeroen van Bergenhenegouwen, Sebastian Tims, Johan de Vogel-van den Bosch, Justin Roberts, Daisy Jonkers, Louise Harvey, Ardy van Helvoort

Registry-linked trialAbstract read
In one paragraph

Article in Current developments in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06115057 (The Investigation of Gastrointestinal Tolerance of a Novel Fibre Blend Among ≥45-<70-year-old Men and Women), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06115057 early_phase1completednot on this map

The Investigation of Gastrointestinal Tolerance of a Novel Fibre Blend Among ≥45-<70-year-old Men and Women

TypeinterventionalSponsorNutricia ResearchRan2023 to 2023Enrolled43ConditionsGastrointestinal Tolerance of Dietary FiberArmsFiber
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lotte DopheideDanone Research & Innovation, Utrecht, The Netherlands.
Marta KoziorDanone Research & Innovation, Utrecht, The Netherlands.
Amra BucoDanone Research & Innovation, Utrecht, The Netherlands.
Jeroen van BergenhenegouwenDanone Research & Innovation, Utrecht, The Netherlands.
Sebastian TimsDanone Research & Innovation, Utrecht, The Netherlands.
Johan de Vogel-van den BoschDanone Research & Innovation, Utrecht, The Netherlands.
Justin RobertsDanone Research & Innovation, Utrecht, The Netherlands.
Daisy JonkersDepartment of Gastroenterology-Hepatology, Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, The Netherlands.
Louise HarveyDanone Research & Innovation, Utrecht, The Netherlands.
Ardy van HelvoortDanone Research & Innovation, Utrecht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Adequate fiber intake is associated with health benefits and reduced disease risk. It is hypothesized that consuming a mixture of fiber types with distinct (physico)chemical characteristics, reflective of those naturally present in a nutritionally balanced diet, may help bridge the known "fiber gap" in many populations. However, good gastrointestinal (GI) tolerance of such a mixture of fiber types is essential to reach adequate fiber intake. Objectives: To evaluate GI tolerance of a diverse fiber mixture in healthy adults. Methods: In an open-label, single-arm, single-center study, healthy adults (45‒69 y) consumed 6 g/d of a diverse fiber mixture (FM) (2 × 3 g/d) for 4 wk alongside their habitual diet. FM comprised arabinoxylan, β-glucan, pectin, and resistant starch in proportions similar to those typically consumed in a nutritionally balanced diet. GI tolerance symptoms were assessed weekly using the Gastrointestinal Symptom Rating Scale (GSRS), along with fecal transit type and frequency, digestion-associated quality of life [Digestion Associated Quality of Life Questionnaire (DQLQ)], compliance, safety, and dietary intake. Results: Of 41 enrolled participants, 38 participants completed the study without major protocol deviations. Changes in GSRS dimensions remained below their respective minimal important differences, a measure of clinical relevance, except for the indigestion dimension from baseline to week 1, with a least-square mean and standard error of 0.4 ± 0.2, where the upper 95% confidence interval (0.0, 0.7) reached the minimal important differences of 0.7. GSRS scores remained otherwise stable over time. Weekly fecal frequency significantly increased from baseline to week 1 with least-square mean ± standard error of 1.4 ± 0.4 and 95% confidence interval (0.5, 2.3). No significant changes were observed in fecal frequency (week 4), fecal transit type, and the digestion-associated quality of life questionnaire. Conclusions: Daily consumption of 6 g FM for 4 wk was well tolerated by healthy adults.This trial was registered at clinicaltrials.gov as NCT06115057.

Indexed as

arabinoxylanfiber diversityfiber gapgastrointestinal tolerancehealthy adultsin vitro fermentationpectinresistant starchβ-glucan

Identifiers

PMID42231910
PMCPMC13223861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.